Immunovant Inc
IMVT - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.07B
Close$
$4.94
85.5% downside
Current Fair Value
85.5% downsideOvervalued by 85.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $7.07 Billion |
|---|---|
| Enterprise Value | $6.35 Billion |
| Earnings per Share | $-2.77 |
| Beta | 0.84 |
| Outstanding Shares | 206,667,558 |
Return
| Return on Equity | -77.47% |
|---|---|
| Return on Assets | -66.88% |
| Return on Invested Capital | -62.41% |
Valuation & Multiples
| P/E Ratio | -13.35 |
|---|---|
| PEG | 57.73 |
| Price to Sales | - |
| Price to Book Ratio | 11.39 |
| Enterprise Value to Revenue | 895.17 |
| Enterprise Value to EBIT | -15.49 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 9, 2026
EPS
-$0.47
Est. -$0.74Revenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
February 5, 2027
EPS Estimate
-$0.68
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 2.69, the ratio is above 1, so institutions hold more puts than calls. That is a more cautious stance.
| Put/Call Ratio | 2.6916▲ 253.80% |
|---|---|
| Total Calls | 331,700▼ 81.58% |
| Total Puts | 892,800▲ 222.78% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 28.67%▼ 25.37% |
|---|---|
| Total Invested | $1.99B▼ 53.47% |
| Investors Holding | 167▼ 73.00% |